Skip to content

Altered right amygdala-prefrontal connectivity is associated with symptom severity in major depressive disorder: An exploratory analysis of anxiety subgroups.

Aug 2026 · Neuroscience Letters · pp. 138708 · 0 citations · 41 references
Medicine

TL;DR

The findings identify disrupted right amygdala-MFG connectivity as a potential neural correlate of symptom heterogeneity in MDD, particularly in patients with anxiety symptoms.

Abstract

Background

Major depressive disorder (MDD) is highly prevalent and often complicated by anxiety symptoms, yet the neurobiological features associated with anxious depression remain incompletely characterized. The amygdala-prefrontal cortex (PFC) circuit, central to affect regulation, has been implicated in anxious depressive symptoms.

Methods

We recruited 40 MDD patients and 69 healthy controls (HCs) from Tianjin Anding Hospital. All participants underwent resting-state functional magnetic resonance imaging(fMRI) and clinical assessments. Seed-based functional connectivity (FC) analyses were performed using the bilateral amygdala based on the Automated Anatomical Labeling (AAL) atlas. Group comparisons, partial correlations, and regression analyses tested associations between amygdala-based FC and HDRS-17 symptom dimensions, with subgroup analyses distinguishing MDD patients with and without anxiety.

Results

Compared with HCs, MDD patients exhibited reduced FC between the right amygdala and prefrontal cortex, including the right middle frontal gyrus (MFG) and the left inferior frontal gyrus, triangular part (IFGtri) (GRF: voxel-level p < 0.001, cluster-level p < 0.05). Within the MDD group, higher right amygdala-MFG FC values were associated with HDRS-17 symptoms, including total scores and depressive and somatic symptom dimensions (r = 0.393, p = 0.020; r = 0.360, p = 0.033; r = 0.351, p = 0.039, uncorrected p). In exploratory subgroup analyses, right amygdala-MFG FC showed a positive association with HDRS-17 scores in MDD patients with anxiety (R2 = 0.280, F = 8.957, p = 0.006, Beta = 0.529, t = 2.993, p = 0.006); however, the FC × anxiety subgroup interaction did not reach statistical significance.

Conclusion

Our findings identify disrupted right amygdala-MFG connectivity as a potential neural correlate of symptom heterogeneity in MDD, particularly in patients with anxiety symptoms.

View source

Similar papers

Aug 2026

Gray Matter Volume Alterations in Generalized Anxiety Disorder and Major Depressive Disorder.

BACKGROUND Generalized anxiety disorder (GAD) and major depressive disorder (MDD) are highly comorbid and clinically overlapping, but their shared and differential structural brain alterations remain unclear. This study investigated gray matter volume (GMV) alterations in GAD and MDD using voxel-based morphometry (VBM)...

Jia-Kuai Yu, Shun-Shun Cui, Qin Hu et al. · 0 citations
Sep 2026

Shared and disorder-specific functional alterations in generalized anxiety disorder and major depressive disorder.

BACKGROUND Generalized anxiety disorder (GAD) and major depressive disorder (MDD) show substantial clinical overlap, yet their shared and disorder-specific intrinsic functional abnormalities remain unclear. This study examined regional brain activity and whole-brain functional integration in GAD and MDD using resting-s...

Ting Wang, Shun-Shun Cui, Ming-Ming Zheng et al. · 0 citations
Open access Sep 2026

306. Genetic and neuroimaging correlates of symptom severity in major depressive disorder: an imaging–genetics study

Abstract Background The habenula is a key region involved in mood and sleep regulation and is critically implicated in major depressive disorder (MDD). Aims & Objectives This imaging–genetics study aimed to characterize the relationships among genetic variation, habenula-centered brain connectivity, and clinical featur...

M. Kim, J.-Y. Jung, S.-J. Cho et al. · 0 citations
Open access Aug 2026

Baseline cortical structural features are associated with depressive and cognitive improvement in major depressive disorder

Major depressive disorder (MDD) exhibits substantial clinical and neurobiological heterogeneity, along with marked variability in treatment response, underscoring the need for objective neuroimaging markers to inform personalized interventions. Twenty-two patients with MDD and twenty-one age- and sex-mat...

Yingna Li, Shuping Tian, Siyan Zan et al. · 0 citations
Open access Sep 2026

Associations Between Thalamic Gray Matter Volume and Psychomotor Symptoms in Major Depressive Disorder: A Voxel-Based Morphometry Study

Background Major depressive disorder (MDD) is a heterogeneous disorder with diverse symptom profiles and treatment responses. Psychomotor retardation and agitation represent clinically relevant dimensions of MDD heterogeneity, but their neurobiological basis remains unclear. Given the role of the thalamus in motor regu...

Ya-Xiang Gu, Xin-Lin Wang, Fei Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.